Bupropion-structure.jpg (Bupropion Structure)
Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 71335-2499
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 71335-2499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl713352499)
This is a description for AVIND extended-release tablets containing 300 mg of BuPROPion Hydrochloride, USP. The tablets are to be stored at 20° to 25°C and protected from light. It is important to keep this medication out of reach of children. A warning states not to use it in combination with Zyban or any other medicines containing bupropion hydrochloride. It mentions the potential side effect of drowsiness. Additional information and instructions can be accessed from the provided link for more details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
